Advertisement
Advertisement
IGC
IGC Pharma, Inc.
0.20
USDSponsored
+0.01
+5.82%
Nov 06, 15:59 UTC -5
Closed
After-Market
0.20
0.00
-1.00%
IGC Pharma, Inc. (IGC) Earnings
IGC Earnings Reports
Positive Surprise Ratio
IGC beat 4 of 6 last estimates.
67%
Next Report
Date of Next Report
Nov 18, 2026
Estimate for Q2 27 (Revenue/ EPS)
$250.48K
/-$0.01
Implied change from Q1 27 (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
IGC Pharma, Inc. earnings per share and revenue
On Aug 12, 2026, IGC reported earnings of -- USD per share (EPS) for Q1 27, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 248.46 thousand, with a --% difference.
Looking ahead to Q2 27, -- analysts forecast an EPS of -0.01 USD, with revenue projected to reach 250.48 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ZOETIS INC.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.52
Actual
$1.75
Surprise
+14.64%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.38
Actual
-$0.38
Surprise
+1.04%
Guardian Pharmacy Services, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.30
Actual
$0.33
Surprise
+7.84%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.06
Surprise
+144.90%
Cronos Group Inc. Common Share
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.89
Actual
$1.96
Surprise
+3.17%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.32
Actual
$0.36
Surprise
+9.16%
ARS Pharmaceuticals, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.36
Surprise
-11.15%
Profound Medical Corp. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.18
Actual
-$0.21
Surprise
-11.41%
Akebia Therapeutics, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.03
Actual
-$0.04
Surprise
-6.95%
FAQ
What were IGC Pharma, Inc.'s earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, IGC Pharma, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to IGC Pharma, Inc.'s Q1 2027 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is IGC Pharma, Inc. expected to report next?
The next earning report is scheduled for Nov 18, 2026.
What are the forecasts for IGC Pharma, Inc.'s next earnings report?
Based on --
analysts, IGC Pharma, Inc. is expected to report EPS of -$0.01 and revenue of $250.48K for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.